LGM
IMA

Logos Global Management’s ImageneBio Inc IMA Stock Holding History

Logos Global Management’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-14,857
Closed -$1.09M – 38
2022
Q1 		$1.09M Sell
14,857
-10,131
-41% -$1.08M 0.14% 42
2021
Q4 		$3.76M Hold
24,988
– – 0.39% 48
2021
Q3 		$3.78M Hold
24,988
– – 0.27% 46
2021
Q2 		$4.21M Sell
24,988
-10,000
-29% -$2.21M 0.35% 47
2021
Q1 		$11.9M Buy
+34,988
New +$12M 1.16% 19

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Logos Global Management's IMA Position: Q2 2022 in Review

Logos Global Management sold out of ImageneBio Inc (IMA) in Q2 2022, closing a stake of 14,857 shares — an estimated $1.09M sold.

Logos Global Management first reported a position in IMA in Q1 2021 and held it in 5 quarters. The position peaked at $11.9M in Q1 2021. 46 funds tracked by Wall St. Rank hold IMA as of Q2 2022.

  • Logos Global Management reported no remaining ImageneBio Inc position as of Q2 2022 after selling out during the quarter.
  • Logos Global Management sold 14,857 ImageneBio Inc shares in Q2 2022, an estimated $1.09M.
  • Logos Global Management first reported a position in ImageneBio Inc in Q1 2021 and held it in 5 quarters.
  • Logos Global Management's ImageneBio Inc position peaked at $11.9M in Q1 2021.
  • 46 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2022.

Based on Logos Global Management's 13F filing for Q2 2022, filed 15 Aug 2022.